Advancing the Vaccine Law Dialogue

Pre-conference: September 13 Washington, D.C.

Clint Hermes

Clint D. Hermes

Counsel, Bass, Berry & Sims


Clint Hermes draws on his deep experience as general counsel at two teaching hospitals to advise clients on regulatory, accreditation, and corporate governance matters in academic medicine. In addition, Clint also offers clients practical advice and insights on all regulatory and contracting aspects of human and animal research.

Clint’s accomplishments on behalf of academic medical centers have been as varied as negotiating complex academic affiliation agreements; implementing enterprise risk management programs; securing dismissal of a qui tam action involving federal grant compliance; preparing clients for Joint Commission, AAHRPP, and ACGME reviews; lobbying HHS for changes to a PREP Act declaration; obtaining a favorable OIG Advisory Opinion; and establishing healthcare and humanitarian programs overseas.

Clint has extensive experience with the regulation of human and animal research, clinical trial registration and transparency, conflicts of interest, federal grants, biospecimens, data sharing, and expanded access to investigational products. His work on behalf of the research missions of academic medical centers and life sciences companies has taken him throughout Africa, Asia, the Middle East, and South America. He has served on numerous Institutional Review Boards (IRBs) in the United States and abroad, including as Vice Chair of a Harvard-affiliated IRB and of a biobank IRB abroad, and as science policy advisor to a foreign government.

Clint has authored numerous articles and book chapters (including one published by Cambridge University Press) in the areas of international health projects and biomedical research. He obtained his undergraduate degree from Yale University, and his Juris Doctor, magna cum laude, from Harvard Law School.

Mr.  Hermes spoke on the following panels:

September 15, 2022 9:30AM-10:30AM — International Vaccine Law